Publicaciones en colaboración con investigadores/as de Clínica Universitaria de Navarra (76)

2024

  1. Prediction model for major bleeding in anticoagulated patients with cancer-associated venous thromboembolism using machine learning and natural language processing

    Clinical and Translational Oncology

  2. Profilaxis de la enfermedad tromboembólica venosa en pacientes hospitalizados por patología médica desde los servicios de urgencias españoles: estudio PROTESU II

    Emergencias : revista de la Sociedad Espanola de Medicina de Emergencias, Vol. 36, Núm. 4, pp. 271-280

2023

  1. Antithrombotic management of patients with deep vein thrombosis and venous stents: an international registry

    Journal of Thrombosis and Haemostasis, Vol. 21, Núm. 12, pp. 3581-3588

  2. Venous thromboembolism in cancer patients: ESMO Clinical Practice Guideline

    Annals of Oncology, Vol. 34, Núm. 5, pp. 452-467

  3. When and How to Use Reversal Agents for Direct Oral Anticoagulants?

    Current Cardiology Reports, Vol. 25, Núm. 5, pp. 371-380

2022

  1. Long-Term Outcome of Critically Ill Advanced Cancer Patients Managed in an Intermediate Care Unit

    Journal of Clinical Medicine, Vol. 11, Núm. 12, pp. 3472

2021

  1. Characteristics of isolated superficial vein thrombosis and diagnostic-therapeutic management in spanish hospital emergency departments:The altamira study

    Emergencias, Vol. 33, Núm. 6, pp. 433-440

  2. Meta-Analysis of Reversal Agents for Severe Bleeding Associated With Direct Oral Anticoagulants

    Journal of the American College of Cardiology, Vol. 77, Núm. 24, pp. 2987-3001

  3. Prediction of major bleeding in anticoagulated patients for venous thromboembolism: Comparison of the RIETE and the VTE-BLEED Scores

    TH Open, Vol. 5, Núm. 3, pp. e319-e328

  4. Profiles of patients with venous thromboembolic disease in the emergency department and their medium-term prognosis: Data from the ESPHERIA registry

    Emergencias, Vol. 33, Núm. 2, pp. 107-114

2020

  1. Evaluating prophylactic heparin in ambulatory patients with solid tumours: a systematic review and individual participant data meta-analysis

    The Lancet Haematology, Vol. 7, Núm. 10, pp. e746-e755

  2. The Khorana score for prediction of venous thromboembolism in cancer patients: An individual patient data meta-analysis

    Journal of Thrombosis and Haemostasis, Vol. 18, Núm. 8, pp. 1940-1951

2019

  1. Improvement of appropriate pharmacological prophylaxis in hospitalised cancer patients with a multiscreen e-alert system: a single-centre experience

    Clinical and Translational Oncology, Vol. 21, Núm. 6, pp. 805-809

2018

  1. Cancer-associated thrombosis: Beyond clinical practice guidelines-A multidisciplinary (SEMI-SEOM-SETH) expert consensus

    TH Open, Vol. 2, Núm. 4, pp. e373-e386

  2. Causes of Death in Patients with Venous Thromboembolism Anticoagulated with Direct Oral Anticoagulants: A Systematic Review and Meta-Analysis

    Seminars in Thrombosis and Hemostasis, Vol. 44, Núm. 4, pp. 377-387

  3. Insights into venous thromboembolism prevention in hospitalized cancer patients: Lessons from a prospective study

    PLoS ONE, Vol. 13, Núm. 8

  4. Outcomes beyond the Third Month of Anticoagulation in Patients Aged >75 Years with a First Episode of Unprovoked Venous Thromboembolism

    TH Open, Vol. 2, Núm. 4, pp. e428-e436

  5. Tromboembolismo venoso

    Hemostasia y trombosis: manual práctico (Arán), pp. 139-148

2017

  1. Screening for occult cancer in patients with unprovoked venous thromboembolism

    Annals of Internal Medicine, Vol. 167, Núm. 6, pp. 410-417

2016

  1. Antidotes for the new oral anticoagulants: Reality and expectations

    Medicina Clinica, Vol. 146, Núm. 11, pp. 488-490